Risk factors for the failure to achieve normal albumin serum levels after albumin transfusion in neonates

Main Article Content

Nadya Arafuri
Pudjo Hagung Widjajanto
Ekawaty L. Haksari

Abstract

Background Albumin transfusion for the treatment of neonatal hypoalbuminemia may reduce morbidity. In conditions with disrupted endothelial integrity (e.g., sepsis and critical illness), the administered albumin may leak into the interstitial space, hence, serum albumin levels may fall below expected levels after transfusion. To date, few studies have been done to evaluate the risk factors for failure to achieve normal neonatal albumin levels after transfusion.
Objectives To determine the risk factors for failure to achieve normal neonatal albumin levels after transfusion.
Methods We performed a case-control study in the Neonatal Ward of Dr. Sardjito Hospital from 2007 to 2012. Normal albumin level was defined as above 3 g/dL. The case group included neonates with post-transfusion albumin levels <3 g/dL and the control group included those with post-transfusion albumin ≥3 g/dL. Subjects received intravenous transfusions of 25% or 20% albumin according to the clinical standard of the Neonatal Ward of Dr. Sardjito Hospital. Neonates with very low birth weight, severe birth trauma, burn injuries, severe bleeding, or incomplete medical records were excluded. The data were analyzed with logistic regression test.
Results From January 2007 to December 2012, 124 neonates were enrolled in the study. Multivariate analysis showed that low albumin levels before transfusion (OR 12.27; 95%CI 2.17 to 69.30), presence of critical illness (OR 4.01; 95%CI 1.49 to 10.79), diagnosis of sepsis (OR 3.56; 95%CI 1.36 to 9.32), and the >24-hour interval between albumin examination and transfusion (OR 0.06; 95%CI 0.01 to 0.37) were significant risk factors affecting the failure to achieve normal albumin levels.
Conclusions Failure to achieve normal albumin levels after transfusion in neonates was significantly associated with low albumin level prior to transfusion, critical illness, sepsis, and >24-hour interval between transfusion and post-transfusion albumin examination.[Paediatr Indones. 2016;56:129-33.].

Article Details

How to Cite
1.
Arafuri N, Widjajanto P, Haksari EL. Risk factors for the failure to achieve normal albumin serum levels after albumin transfusion in neonates. PI [Internet]. 1Jul.2016 [cited 17Jul.2019];56(3):129-3. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/225
Section
Neonatology
Received 2016-08-18
Accepted 2016-08-18
Published 2016-07-01

References

1. Jardine LA, Jenkins-Marsh S, Davies MW. Albumin infusion for low serum albumin in preterm newborn infants. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004208. DOI: 10.1002/14651858.CD004208.pub2.
2. Porto BS, Jorge SM, de Assis MG. Exogenous human albumin supplementation in total parenteral nutrition of critically ill newborns. J Pediatr (Rio J). 2005;81:41–6.
3. Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med. 2004;32:2029–38.
4. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319–34.
5. Morris I, Molloy EJ. Albumin administration in the management of neonatal hypoalbuminaemia. Arch Dis Child Fetal Neonatal Ed. 2008;93:326.
6. Bunt JE, Rietveld T, Schierbeek H, Wattimena JLD, Zimmermann LJ, van Goudoever JB. Albumin synthesis in preterm infants on the first day of life studied with [1-13C]leucine. Am J Physiol Gastrointest Liver Physiol. 2007;292:1157–61.
7. Cartlidge PH, Rutter N. Serum albumin concentrations and oedema in the newborn. Arch Dis Child. 1986;61:657-60.
8. Uhing MR. The albumin controversy. Clin Perinatol. 2004;31:475–88.
9. Margason MP, Soni NC. Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients. Br J Anaesth. 2004;92:821-6.
10. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85:599-610.
11. Allison SP, Lobo DN, Stanga Z. The treatment of hypoalbuminaemia. Clin Nutr. 2001;20:275–9.
12. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G. Recommendations for the use of albumin and immunoglobulins. Blood Transfus. 2009;7:216–34.
13. Perinatology Department, Dr. Sardjito hospital. Clinical standard of albumin transfusion in neonates. Yogyakarta; 2010.
14. Palmese S, Ughi L, Iacono F, Scibelli G, Robertis EDE, Natale A, et al. Exogenous albumin administration to hypoalbuminemic patients in the ICU setting: a retrospective analysis. Riv Ital Di Nutr Parenter Ed Enterale. 2000;23:36–42.
15. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JM. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci. 1998;95:459-65.
16. Falcao H, Japiassu AM. Albumin in critically ill patients: controversies and recommendations. Rev Bras Ter Intensiva. 2011;23:87–95.
17. Peter, TJ. All about albumin, biomedical, genetics and medical application. San Diego: Acad. Press; 2000. p. 188-250.
18. Sahu KK, Idris MZ, Agarwal M, Singh SK, Ali W, Pratap S, et al. Umbilical cord blood nutrients among low birth weight and normal birth weight babies in primary health care setup in Lucknow, India. Journal of Biological and Scientific Opinion. 2013;1:300–3.
19. Zlotkin SH, Casselman CW. Percentile estimates of reference values for total protein and albumin in sera of premature infants (less than 37 weeks of gestation). Clin Chem. 1987;33:411-3.
20. Lee M, Youn S, Lim BK, Kim JS. Serum albumin concentrations and clinical disorders by gestational ages in preterm babies. Korean J Pediatr. 2005;48:148–153.